Study investigating the effect of irsogladine maleate on PPI-resistant GERD
Not Applicable
Recruiting
- Conditions
- GERD
- Registration Number
- JPRN-UMIN000003013
- Lead Sponsor
- Yoshikazu Kinoshita
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Cases taking H2RA,mucosa defencing agents,mucoprotective agents. Cases who took PPI in the recent 2 weeks. Cases taking NSAIDs,salicylate, antimuscarinic agents,prokinetics, PG. Cases whose inclusion is considered to be inappropriate by the attending physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical symptoms and QOL evaluated by questionaires.
- Secondary Outcome Measures
Name Time Method